Search for: "MAJOR PHARMACEUTICALS" Results 941 - 960 of 4,361
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Sep 2019, 5:24 am
Given that courts tend to have broad discretion in deciding irreparable harm, the Court's rule would seem to lead to effectively exclude "appropriate compensation" in the vast majority of cases. [read post]
20 Sep 2019, 9:23 am by Heather Joy
It is an open access journal, archived by major databases including EBSCO host, Hein Online, Westlaw Asia. [read post]
20 Sep 2019, 4:23 am by Sean Hayes
Major Regulations of the Korean In Vitro Act 2020 The Minister of Food and Drug Safety “…shall classify and designate the class of each in vitro diagnostic medical device in conformity with the intended use of each device and differences in their potential risks to individual and/or public health. [read post]
19 Sep 2019, 12:12 pm by Corbin Bridge
Now Amazon truly does have more than a foot in the door to the pharmaceutical market. [read post]
18 Sep 2019, 5:00 pm by Nate Nead
Now Amazon truly does have more than a foot in the door to the pharmaceutical market. [read post]
16 Sep 2019, 8:57 am
True, Huawei is also a major manufacturer of mobile phones, whereas some of the other major patent holders in the telecoms industry are not [though they rarely restrict themselves to mere licensing of technology: Ericsson, for instance, is also a major provider of telecom hardware]. [read post]
16 Sep 2019, 12:08 am
This is definitely a “to be continued” issue, with major  consequences for both the future of the interrelationship between IP and competition law as well as for the future regulation of the pharmaceutical industry. [read post]
13 Sep 2019, 9:22 pm by mgreen
This one who reported on the pharmaceutical giant selling defective or mislabeled drugs. [read post]
13 Sep 2019, 11:09 am by Dennis Crouch
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
13 Sep 2019, 6:00 am by Guest Blogger
[vi]And then-Justice Rehnquist might have joined the majority in Washington v. [read post]
12 Sep 2019, 5:44 pm by Doyle, Barlow & Mazard PLLC
  Moreover, major drug manufacturers such as Pfizer, Shire, and Sanofi have filed antitrust suits challenging rebate walls as antitrust violations. [read post]
12 Sep 2019, 5:45 am by Charles Gallmeyer
Plaintiffs argued the science behind this technique is unproven and not supported by major medical organizations. [read post]
10 Sep 2019, 6:46 am by Jordan Ross
The lawsuit is the second legal challenge from the group within the past three months after the Canadian government made major reforms to lower drug prices. [read post]
6 Sep 2019, 12:06 pm by Rebecca Tushnet
Genus also sued First Databank, a pharmaceutical pricing list company. [read post]
3 Sep 2019, 12:46 pm by Mitch Stoltz
Many advisers and lobbyists from the pharmaceutical industry now work for one of these organizations. [read post]
3 Sep 2019, 9:36 am by Florian Mueller
While significant parts of the document focus on international trade with a particular emphasis on pharmaceutical patents, it provides a pretty good overview. [read post]
31 Aug 2019, 8:25 am by Simmons Hanly Conroy
Johnson & Johnson is named as a defendant in the MDL, along with 21 other pharmaceutical companies, including Janssen, Allergan, Teva Pharmaceuticals and Purdue. [read post]
28 Aug 2019, 12:34 pm by Keeley A. McCarty and Bryce Chadwick
The MOA covers all aspects of the medical logistics support DLA provides to DHA, including pharmaceuticals, medical/surgical supplies, and healthcare technology equipment. [read post]